Point-of-care testing: Horiba Medical and CEA-Leti extend partnership

Categorie(s) : Industry, News, Research

Published : 5 October 2020

The Point-of-Care Testing (POCT) project run by Hemacount (a joint laboratory of Horiba Medical* and CEA-Leti) since 2014 is investigating ways to replace bulky, complex medical analysis systems with compact, easy-to-use point-of-care devices. The partners recently announced that they would be extending the joint lab, which has already produced a dozen patents.
The focus of the partners’ research is to combine a microfluidic circuit with a lensless imager to form a portable complete blood count (CBC) testing device. The objective is to obtain a device that offers the same level of performance as today’s lab tests. The research will also pave the way toward other automated point-of-care biological analyses.

*A subsidiary of Japan-based Horiba, a manufacturer of precision instruments for analysis and measurement

Contact: nicolas.verplanck@cea.fr

More information